April 14, 2021
In the era of modern clinical development, several companies are turning towards novel and innovative approaches such..
March 18, 2021
Over the past ten years High-Performance Computing (HPC) has transformed medical research through advances in genomics,..
February 19, 2021
C-Suite and R&D Decision-Makers are always striving to make evidence-driven decisions. Yet the rules by which evidence..
February 18, 2021
In the last few years, there has been a growing interest in historical borrowing or augmented trials. There is an..
February 2, 2021
As the use of master protocols becomes more prevalent in drug development, Bayesian methods are extensively used to..
January 26, 2021
Bayesian models offer a flexible way of incorporating historical controls in the analysis of trial data (whether single..
December 17, 2020
As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation..
December 16, 2020
As we prepare to close the door on 2020, we asked Pantelis Vlachos, Principal/Strategic Consultant for Cytel, to share..
December 15, 2020
When designing clinical trials, biostatisticians and clinical development teams are often faced with a conundrum. Given..